Miaomiao Li
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Molecular Biology top 5%
- RNA modifications and cancer 12
- CRISPR and Genetic Engineering 11
- Ubiquitin and proteasome pathways 8
- RNA and protein synthesis mechanisms 6
- Plant Science top 5%
- Plant Molecular Biology Research 8
- Aging top 10%
-
- Genetic Mapping and Diversity in Plants and Animals 7
-
- interferon and immune responses 6
- Co-authors
- Arne KlunglandYongming WangZhike LuWei WangRajikala SuganthanHailing ShiChuan HeXu Zhao
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Miaomiao Li
135 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 325
- Molecular Biology 1.4k
- Plant Science 615
- Aging 26
- Renewable Energy, Sustainability and the Environment 223
Countries citing papers authored by Miaomiao Li
This map shows the geographic impact of Miaomiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaomiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaomiao Li more than expected).
Fields of papers citing papers by Miaomiao Li
This network shows the impact of papers produced by Miaomiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaomiao Li. The network helps show where Miaomiao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miaomiao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 31 | |
| 10 | 2023 | 27 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 21 | |
| 13 | 2022 | 15 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 44 | |
| 17 | 2021 | 24 | |
| 18 | 2020 | 14 | |
| 19 | 2017 | 50 | |
| 20 | Establishment and characterization of a new cell line Bm-Em-1 from Bombyx mori embryos | 2011 | 4 |
About Miaomiao Li
Miaomiao Li is a scholar working on Virology, Cancer Research and Molecular Biology, having authored 141 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), CRISPR and Genetic Engineering (11 papers), Ubiquitin and proteasome pathways (8 papers), Plant Molecular Biology Research (8 papers), MicroRNA in disease regulation (7 papers), Genetic Mapping and Diversity in Plants and Animals (7 papers), interferon and immune responses (6 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Cancer Research (325 citations), Molecular Biology (1.4k citations) and Plant Science (615 citations). Miaomiao Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Arne Klungland, Yongming Wang, Zhike Lu, Wei Wang, Rajikala Suganthan, Hailing Shi, Chuan He, Xu Zhao, Qingfei Pan and Magnar Bjørås. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.